A detailed history of Eam Global Investors LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Eam Global Investors LLC holds 37,521 shares of PRCT stock, worth $2.34 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares
37,521
Holding current value
$2.34 Million
% of portfolio
0.64%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$67.27 - $99.45 $2.52 Million - $3.73 Million
37,521 New
37,521 $3.02 Million
Q3 2022

Nov 14, 2022

SELL
$30.9 - $50.65 $344,009 - $563,886
-11,133 Reduced 25.82%
31,980 $1.33 Million
Q2 2022

Aug 12, 2022

BUY
$29.23 - $44.45 $1.26 Million - $1.92 Million
43,113 New
43,113 $1.41 Million

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $2.78B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Eam Global Investors LLC Portfolio

Follow Eam Global Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Global Investors LLC with notifications on news.